BSE To Consider Bonus Share Issue On March 30
BSE Ltd. said on Wednesday that it will consider issuing bonus shares during its board meeting on March 30.
If approved, this will be BSE's second bonus share issue in three years. In February 2022, the exchange issued a 2:1 bonus share, giving investors two additional shares for every share held.
The announcement came after the company's shares have risen 94% over the past 12 months. Since its listing in 2017, the stock has increased 15.66 times.
BSE has issued dividends 22 times since debuting on the stock exchanges. As of September 2024, the company had a net cash equivalent of Rs 2,532.38 crore.
UBS Global Research, on March 17, had initiated coverage on the exchange with a 'buy' call. The firm posted a price target of Rs 5,350, implying an upside of 19.31% from Tuesday's closing stock price.
The research firm is optimistic on an improvement in volumes, as volumes moving from NSE have not been fully priced in. They also cited better broker management and the offering of an alternate expiry day to NSE as key triggers for their stance.
UBS noted that NSE being the default exchange put BSE at a disadvantage. This disadvantage kept BSE's cash market share lower, as NSE dominates 93–94% market share. Hence, implementing a common contract note can help generate a combined order book and neutrality among brokers, said the firm.
Shares of the company closed 3.8% lower at Rs 4,474.7 per share, compared to a 0.77% decline in the NSE Nifty 50. It has risen 93.69% in the last 12 months and fallen 15.79% on a year-to-date basis.
Ten out of the 13 analysts tracking BSE have a 'buy' rating on the stock, two recommend a 'hold' and one suggests a 'sell', according to Bloomberg data. The 12-month analysts' consensus target price on the stock is Rs 5,753.73, implying an upside of 28.6%.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets